MiR-663a Inhibits Radiation-Induced Epithelium-to-Mesenchymal Transition by Targeting TGF-β1

Pei Qu1, Zhi Ang Shao1, Bing Wang1

  • 1Key Laboratory of Space Radiobiology of Gansu Province & Key Laboratory of Heavy Ion Radiation Biology and Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, Gansu, China;University of Chinese Academy of Sciences, Beijing 100049, China.

Abstract

Insights

MicroRNA-663a (miR-663a) suppresses radiation-induced Epithelium-to-mesenchymal transition (EMT) by targeting TGF-β1. This finding highlights miR-663a as a potential therapeutic target for mitigating radiation-induced cellular changes.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Radiation Oncology

Background:

  • MicroRNA-663a (miR-663a) is implicated in radiation responses and the radiation-induced bystander effect.
  • Epithelium-to-mesenchymal transition (EMT) is a critical process in development and disease, often influenced by radiation.
  • The precise role of miR-663a in radiation-induced EMT requires further elucidation.

Purpose of the Study:

  • To investigate the function of miR-663a in the context of radiation-induced EMT.
  • To determine the molecular mechanisms underlying miR-663a's involvement in radiation-induced EMT.

Main Methods:

  • Epithelium-to-mesenchymal transition (EMT) was induced using TGF-β1 or irradiation (IR).
  • miR-663a transfection was performed, followed by assessments of cell migration and morphology.
  • Expression levels of miR-663a, TGF-β1, and EMT markers were quantified.

Main Results:

  • miR-663a transfection suppressed TGF-β1- or IR-induced enhancement of cell migration and mesenchymal characteristics.
  • Both X-ray and carbon ion irradiation upregulated TGF-β1 and downregulated miR-663a.
  • miR-663a-mediated silencing of TGF-β1 reversed radiation-induced EMT.

Conclusions:

  • miR-663a exerts an EMT-suppressing effect in radiation-induced EMT.
  • The mechanism involves the modulation of TGF-β1 signaling by miR-663a.
  • miR-663a represents a potential therapeutic target for managing radiation-induced EMT.